Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis [Phase 3]
Phase 3 trial results compare two doses of CP-690,550 (tofacitinib) and the active comparator adalimumab (Humira) against placebo in rheumat…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate [Phase 3]
A two-year Phase 3 study of CP-690,550 (tofacitinib) in rheumatoid arthritis patients on background methotrexate completed; results were pos…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis [Phase 2]
Pfizer completed a Phase 2 trial to evaluate the mechanism of action of CP-690,550 (tofacitinib) in rheumatoid arthritis and posted the resu…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis [Phase 2]
Phase 2 trial comparing six doses of CP-690,550 (tofacitinib) plus methotrexate to placebo plus methotrexate in rheumatoid arthritis; result…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
This trial compares the safety and pharmacokinetics of Hanmi's HCP1004 with Vimovo (naproxen/esomeprazole) in healthy Korean male volunteers…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis [Phase 2]
Pfizer conducted a Phase 2 trial in patients diagnosed with rheumatoid arthritis; results were posted in January 2013.
-
CLINICAL_TRIALS trial_result · 2013-01-01Clinical Trial Update: Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550
This clinical trial update reports long-term safety data for tofacitinib (CP-690,550) in subjects with rheumatoid arthritis who participated…
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial evaluating Revamilast in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-25Clinical Trial Update: Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan [Phase 2]
Pfizer-sponsored Phase 2 trial in Japan evaluating five doses of CP-690,550 (tofacitinib) vs placebo for rheumatoid arthritis has completed …
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Agility LP Ankle Arthroplasty Outcomes
A completed clinical trial assessing outcomes of the Agility LP ankle arthroplasty in patients with rheumatoid arthritis, osteoarthritis, an…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis [Phase 3]
Phase 3 study evaluating the safety and efficacy of modified-release prednisone (Lodotra) for active rheumatoid arthritis has completed, wit…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis [Phase 2]
A Phase 2 clinical trial evaluating four doses of VX-509 in adults with active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550 [Phase 2]
Phase 2 trial assessing the effect of atorvastatin on cholesterol in patients with rheumatoid arthritis who are taking tofacitinib (CP-690,5…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients [Phase 3]
A Phase 3 trial evaluating the combination of tocilizumab with methotrexate for moderate-to-severe rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Web-based Support to Manage Arthritis Pain [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating a web-based tool to help manage arthritis pain.
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2) [Phase 3]
This Phase 3 study evaluates subcutaneous golimumab added to DMARDs for rheumatoid arthritis, followed by an intravenous/subcutaneous golimu…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Co-Administration Of Methotrexate And CP-690,550 [Phase 1]
Phase 1 results report on co-administering methotrexate with CP-690,550 (tofacitinib) in rheumatoid arthritis; results were posted in Decemb…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) [Phase 4]
Phase 4 study VISARA evaluated the effects of RoActemra/Actemra (tocilizumab) on immune responses to vaccination in patients with rheumatoid…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA) [Phase 3]
A Phase 3 trial evaluating changes in joint inflammation via ultrasonography in rheumatoid arthritis patients was terminated; results were p…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care
This clinical trial update reports demographics, compliance, tolerability, and safety data for patients with rheumatoid arthritis, psoriatic…
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Improvement of a Physically Active Lifestyle [NA]
A completed clinical trial investigating the impact of improving a physically active lifestyle on several conditions including osteoarthriti…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 3]
Phase 3 study evaluating tocilizumab's effect on markers of atherogenic risk in patients with moderate-to-severe rheumatoid arthritis; resul…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Rituximab for the Treatment of Early Rheumatoid Arthritis (RA) [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 evaluation of Rituximab for early rheumatoid arthritis; the trial was terminated and results …
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II [Phase 2]
A Phase II trial of HuMax-CD20 for active rheumatoid arthritis has completed. The study was sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient [Phase 3]
Phase 3 clinical trial investigating corticosteroids and anti-TNF therapy in methotrexate-inadequate responder patients with rheumatoid arth…